# Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana

> **NCT02593734** · PHASE4 · COMPLETED · sponsor: **University of Ghana Medical School** · enrollment: 139 (actual)

## Conditions studied

- Schizophrenia
- Mood Disorders,
- Anxiety Disorder

## Interventions

- **DRUG:** olanzapine
- **DRUG:** risperidone
- **DRUG:** amitryptaline
- **DRUG:** fluoxetine

## Key facts

- **NCT ID:** NCT02593734
- **Lead sponsor:** University of Ghana Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 139 (ACTUAL)
- **Last updated:** 2015-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02593734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02593734, "Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02593734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*